Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation.
Aeder
M I
MI
Research Medical Center, Kansas City, Missouri.
Shield
C F
CF
Tegtmeier
G E
GE
Bayer
W
W
Luger
A M
AM
Nelson
P W
PW
Pierce
G E
GE
Polito
A
A
Wilber
J C
JC
Johnson
P
P
D000956:Antigens, Viral / Q000032:analysis / Q000276:immunology; D002102:Cadaver; D004797:Enzyme-Linked Immunosorbent Assay; D016027:Heart Transplantation / Q000502:physiology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000635:transmission*; D018937:Hepatitis C Antibodies; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D016031:Liver Transplantation / Q000502:physiology*; D016133:Polymerase Chain Reaction / Q000379:methods; D011994:Recombinant Proteins / Q000032:analysis / Q000276:immunology; D012189:Retrospective Studies; D014019:Tissue Donors
D000956:Antigens, Viral; D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D011994:Recombinant Proteins